Pharmacokinetic Interaction of Zonisamide in Rats. Effect of Zonisamide on Other Antiepileptics

The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was...

Full description

Saved in:
Bibliographic Details
Published inBiological & pharmaceutical bulletin Vol. 16; no. 7; pp. 722 - 725
Main Authors KIMURA, Masahiko, MIYAKE, Katsushi, TANAKA, Naomi, KITAURA, Teruaki, KIMURA, Yasuhiro, FUKUCHI, Hiroshi
Format Journal Article
LanguageEnglish
Published Japan The Pharmaceutical Society of Japan 1993
Japan Science and Technology Agency
Subjects
Online AccessGet full text
ISSN0918-6158
1347-5215
DOI10.1248/bpb.16.722

Cover

Abstract The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t1/2 and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the Vd/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.
AbstractList The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t 1/2 and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the Vd/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t 1/2 and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the Vd/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.
The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t1/2 and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the Vd/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.
The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t sub(1/2) and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the V sub(d)/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.
The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated in rats. Additionally, the influence of ZNS on the serum protein binding, erythrocyte distribution and metabolism of these antiepileptics was studied in vitro. The t 1/2 and AUC values of PB were significantly increased by ZNS coadministration, and a significant decrease in the Vd/F value of PHT was observed after multiple dosing of ZNS. By contrast, ZNS showed no significant effect on VPA and CBZ kinetics. No significant effect of ZNS was observed in the serum protein binding, erythrocyte distribution or metabolism of other antiepileptics. These results suggest that ZNS has little effect on the pharmacokinetic behaviors of other antiepileptic drugs.
Author MIYAKE, Katsushi
TANAKA, Naomi
KITAURA, Teruaki
KIMURA, Yasuhiro
KIMURA, Masahiko
FUKUCHI, Hiroshi
Author_xml – sequence: 1
  fullname: KIMURA, Masahiko
– sequence: 1
  fullname: MIYAKE, Katsushi
– sequence: 1
  fullname: TANAKA, Naomi
– sequence: 1
  fullname: KITAURA, Teruaki
– sequence: 1
  fullname: KIMURA, Yasuhiro
– sequence: 1
  fullname: FUKUCHI, Hiroshi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8401412$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1r3DAQxUVJSDdpLr0XDIUeCt5K1oftY1jSNhBIKe0lFzGWR422tuxK2kP--8rZbQ5LIRfp8H7zNHrvnJz4ySMhbxlds0o0n7q5WzO1rqvqFVkxLupSVkyekBVtWVMqJpvX5DzGLaW0phU_I2eNoEywakX0twcII5jpt_OYnClufMIAJrnJF5Mt7ifvIoyux8L54jukuC6urUWTjtSM36UHDMWVTw5nN-Cc7eIbcmphiHh5uC_Iz8_XPzZfy9u7Lzebq9vSKCpSCU0NFEwrKRdW9EJ0zErVdr1d9mRSdYAUuLS9kcitEo2hnCmDUPWy5RW_IB_2vnOY_uwwJj26aHAYwOO0i7qWrcjBsBdBphqp6JPj-yNwO-2Cz5_QTIiWSVnLhXp3oHbdiL2egxshPOpDwFmne92EKcaAVhuXYEk3BXCDZlQvFepcYX5a5wrzyMejkX-m_4U3e3gbE_zCZxRCTn_ABWVty5_w_ZGnnlWTy9fo-V8L07OR
CitedBy_id crossref_primary_10_1016_S0361_9230_00_00333_6
crossref_primary_10_1046_j_1440_1819_2001_00869_x
crossref_primary_10_1111_j_1528_1157_1999_tb00916_x
crossref_primary_10_1016_0163_7258_95_00021_6
crossref_primary_10_1007_BF03190386
crossref_primary_10_1248_yakushi_123_35
crossref_primary_10_1016_0006_8993_96_82386_9
crossref_primary_10_1016_0896_6974_95_00049_6
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
Copyright Japan Science and Technology Agency 1993
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: Copyright Japan Science and Technology Agency 1993
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7U9
8FD
FR3
H94
P64
7X8
DOI 10.1248/bpb.16.722
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Virology and AIDS Abstracts
Neurosciences Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5215
EndPage 725
ExternalDocumentID 3120249861
8401412
10_1248_bpb_16_722
article_bpb1993_16_7_16_7_722_article_char_en
Genre Journal Article
GroupedDBID ---
.55
2WC
53G
5GY
6J9
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFFNX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZXP
1CY
23N
AAYXX
ABJNI
BKOMP
CITATION
JMI
MOJWN
XSB
ZY4
ABTAH
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7U9
8FD
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c604t-a87a0ac95034f4d44b1f569bdf0141156bae0a35fdc5e3f648c0316cea2d59323
ISSN 0918-6158
IngestDate Fri Jul 11 12:27:40 EDT 2025
Fri Jul 11 07:51:27 EDT 2025
Mon Jun 30 10:11:28 EDT 2025
Sat Sep 28 08:39:43 EDT 2024
Tue Jul 01 02:29:07 EDT 2025
Thu Apr 24 23:08:26 EDT 2025
Wed Sep 03 06:08:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c604t-a87a0ac95034f4d44b1f569bdf0141156bae0a35fdc5e3f648c0316cea2d59323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/bpb1993/16/7/16_7_722/_article/-char/en
PMID 8401412
PQID 1449155752
PQPubID 1966364
PageCount 4
ParticipantIDs proquest_miscellaneous_75943471
proquest_miscellaneous_16856032
proquest_journals_1449155752
pubmed_primary_8401412
crossref_citationtrail_10_1248_bpb_16_722
crossref_primary_10_1248_bpb_16_722
jstage_primary_article_bpb1993_16_7_16_7_722_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1993-00-00
PublicationDateYYYYMMDD 1993-01-01
PublicationDate_xml – year: 1993
  text: 1993-00-00
PublicationDecade 1990
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Biological & pharmaceutical bulletin
PublicationTitleAlternate Biol Pharm Bull
PublicationYear 1993
Publisher The Pharmaceutical Society of Japan
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Japan Science and Technology Agency
References 15) I. H. Patel, R.H. Levy and R.E. Cutler, Clin. Pharmacol. Ther., 27, 515 (1980).
18) B.K. Martin, Nature (London), 207, 274 (1965).
11) M. Kimura, N. Tanaka, Y. Kimura, K. Miyake, T. Kitaura, H. Fukuchi and Y. Harada, Chem. Pharm. Bull., 40, 193 (1992).
17) A.H. Anton, J. Pharmacol. Exp. Ther., 134, 291 (1961).
19) G.M. Ihler, Pharmacol. Ther., 20, 151 (1983).
8) M. Kimura, N. Tanaka, Y. Kimura, K. Miyake, T. Kitaura and H. Fukuchi, J. Pharmacobio-Dyn., 15, 631 (1992).
1) J.C. Sackellares, P.D. Donofrio, J.G. Wagner, B. Abou-Khalil, S. Berent and K. Aasved-Hoyt, Epilepsia, 26, 206 (1985).
10) O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, J. Biol. Chem., 193, 265 (1951).
4) T. Ono, K. Yagi and M. Seino, Seishin Igaku, 30, 471 (1988).
20) H. Konishi, K. Morita, T. Ono and H. Shimakawa, Yakuzaigaku, 50, 323 (1990).
9) T. Omura and R. Sato, J. Biol. Chem., 239, 2370 (1964).
5) C. B. Pugh and W.R. Garnett, Clin. Pharm., 10, 335 (1991).
13) Y. Kohda, K. Nishihara, S. Isozaki, Y. Saitoh, F. Nakagawa and Z. Tamura, J. Pharmacobio-Dyn., 6, 46 (1983).
6) J. K. Penry and M.E. Newmark, Ann. Intern. Med., 90, 207 (1979).
16) I.M. Weiner and G.H. Mudge, Am. J. Med., 36, 743 (1964).
3) K. Yagi, M. Seino, T. Mihara, T. Tottori, Y. Numata, M. Tsuji, Y. Inoue, T. Kudo, Y. Watanabe and H. Muranaka, Seishin Igaku, 29, 111 (1987).
7) L. M. Ojemann, R.A. Shastri, A.J. Wilensky, P.N. Friel, R.H. Levy, J. R. McLean and R.A. Buchanan, Ther. Drug. Monit., 8, 293 (1986).
12) K. Yamaoka, T. Tanigawara, T. Nakagawa and T. Uno, J. Pharmacobio-Dyn., 4, 879 (1981).
14) K. Nishihara, Y. Kohda, Y. Saitoh and Y. Honda, Folia Psychiatr. Jpn., 33, 315 (1979).
2) A.J. Wilensky, P.N. Friel, L.M. Ojemann, C.B. Dodrill, K.B. McCormick and R.H. Levy, Epilepsia, 26, 212 (1985).
References_xml – reference: 15) I. H. Patel, R.H. Levy and R.E. Cutler, Clin. Pharmacol. Ther., 27, 515 (1980).
– reference: 16) I.M. Weiner and G.H. Mudge, Am. J. Med., 36, 743 (1964).
– reference: 10) O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, J. Biol. Chem., 193, 265 (1951).
– reference: 17) A.H. Anton, J. Pharmacol. Exp. Ther., 134, 291 (1961).
– reference: 5) C. B. Pugh and W.R. Garnett, Clin. Pharm., 10, 335 (1991).
– reference: 7) L. M. Ojemann, R.A. Shastri, A.J. Wilensky, P.N. Friel, R.H. Levy, J. R. McLean and R.A. Buchanan, Ther. Drug. Monit., 8, 293 (1986).
– reference: 13) Y. Kohda, K. Nishihara, S. Isozaki, Y. Saitoh, F. Nakagawa and Z. Tamura, J. Pharmacobio-Dyn., 6, 46 (1983).
– reference: 6) J. K. Penry and M.E. Newmark, Ann. Intern. Med., 90, 207 (1979).
– reference: 18) B.K. Martin, Nature (London), 207, 274 (1965).
– reference: 12) K. Yamaoka, T. Tanigawara, T. Nakagawa and T. Uno, J. Pharmacobio-Dyn., 4, 879 (1981).
– reference: 11) M. Kimura, N. Tanaka, Y. Kimura, K. Miyake, T. Kitaura, H. Fukuchi and Y. Harada, Chem. Pharm. Bull., 40, 193 (1992).
– reference: 20) H. Konishi, K. Morita, T. Ono and H. Shimakawa, Yakuzaigaku, 50, 323 (1990).
– reference: 14) K. Nishihara, Y. Kohda, Y. Saitoh and Y. Honda, Folia Psychiatr. Jpn., 33, 315 (1979).
– reference: 9) T. Omura and R. Sato, J. Biol. Chem., 239, 2370 (1964).
– reference: 2) A.J. Wilensky, P.N. Friel, L.M. Ojemann, C.B. Dodrill, K.B. McCormick and R.H. Levy, Epilepsia, 26, 212 (1985).
– reference: 8) M. Kimura, N. Tanaka, Y. Kimura, K. Miyake, T. Kitaura and H. Fukuchi, J. Pharmacobio-Dyn., 15, 631 (1992).
– reference: 1) J.C. Sackellares, P.D. Donofrio, J.G. Wagner, B. Abou-Khalil, S. Berent and K. Aasved-Hoyt, Epilepsia, 26, 206 (1985).
– reference: 19) G.M. Ihler, Pharmacol. Ther., 20, 151 (1983).
– reference: 4) T. Ono, K. Yagi and M. Seino, Seishin Igaku, 30, 471 (1988).
– reference: 3) K. Yagi, M. Seino, T. Mihara, T. Tottori, Y. Numata, M. Tsuji, Y. Inoue, T. Kudo, Y. Watanabe and H. Muranaka, Seishin Igaku, 29, 111 (1987).
SSID ssj0007023
Score 1.4487745
Snippet The effects of zonisamide (ZNS) on the pharmacokinetics of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) were investigated...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 722
SubjectTerms Animals
Anticonvulsants - blood
Anticonvulsants - pharmacokinetics
Anticonvulsants - pharmacology
antiepileptic drug
Blood Proteins - metabolism
Carbamazepine - blood
Carbamazepine - pharmacokinetics
Drug Interactions
erythrocyte distribution
Erythrocytes - drug effects
Erythrocytes - metabolism
In Vitro Techniques
Isoxazoles - pharmacology
Male
metabolism
pharmacokinetic interaction
Phenobarbital - blood
Phenobarbital - pharmacokinetics
Phenytoin - blood
Phenytoin - pharmacokinetics
protein binding
Protein Binding - drug effects
Rats
Rats, Wistar
Valproic Acid - blood
Valproic Acid - pharmacokinetics
Zonisamide
Title Pharmacokinetic Interaction of Zonisamide in Rats. Effect of Zonisamide on Other Antiepileptics
URI https://www.jstage.jst.go.jp/article/bpb1993/16/7/16_7_722/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/8401412
https://www.proquest.com/docview/1449155752
https://www.proquest.com/docview/16856032
https://www.proquest.com/docview/75943471
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Biological and Pharmaceutical Bulletin, 1993/07/15, Vol.16(7), pp.722-725
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgILEXBB0ThQGWQJMQS5eLc0O8TNOmCrbBQyr1LbJjB8rWtNrSh-7Xc46dOukY15coik-sKN8X5xz7-DuEvJGur5RXpk6alsJhPImcxGeJI33Jk1AIT2gxndOzaDhiH8fhuK02qneX1GJQXN-6r-R_UIVrgCvukv0HZG2ncAHOAV84AsJw_CuMvzS60-fgKqLwKmo_XDbFv8EJvJ7hUvV0IrUwCECt098aveL1drwBXcF38KInag5Dxbxe5cGvlnwndpxEusy_rU2Gi66Mt17Tny50CaN2ujXjFT_na8s_rZX1qE8nS24Shj61MxKY_9edVPQSCEaNGLsdX6MOj-LOYBmbHcnNfzc2G6B_GtKBOYCDmIuBFw3sLV3d7LPP-fHo5CTPjsbZXXLPj2NP6_0O20AodnWhP_t8jVAt9L3f9rzmmtz_Dt75V_XrwEM7INkj8rCJHOiBocFjckdVPbJ1UPF6Nl3SXapzefUiSY88OFzV8euR3YYlyz2atZvtrvb0LVa3fLlF8ht0oh060VlJW7pAC0U6vaeGTDda0RzJRNfJ9ISMjo-yw6HT1N9wishltcOTmLu8SEM3YCWTjAmvDKNUyBKzgyHwF1y5PAhLWYQqKCOWFPCLiArFfRlCXBBsk41qVqmnhJZCBUmkpM8L-Gv4JfQrJZdFWnJRsET0ydvVq8-LRpwea6Rc5BikAkw5wJR7UQ4w9clrazs3kiy3Wn0wCFqb5jNFG2SttjMHMLetuNkRxpY-2Vnhnjdf_BWEyQzLKcQh9P7KNgOcuMjGKzVbgE2UQBAR_MYiDlGTMfb6ZNvwyT5hwvDF-s_-2PlzsmkSb3EqcIds1JcL9QKc41q81Lz_AU55wpM
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetic+interaction+of+zonisamide+in+rats%3A+Effect+of+zonisamide+on+other+antiepileptics&rft.jtitle=Biological+%26+pharmaceutical+bulletin&rft.au=Kimura%2C+M&rft.au=Tanaka%2C+N&rft.au=Kimura%2C+Y&rft.au=Miyake%2C+K&rft.date=1993&rft.issn=0918-6158&rft.volume=16&rft.issue=7&rft.spage=722&rft.epage=725&rft_id=info:doi/10.1248%2Fbpb.16.722&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-6158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-6158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-6158&client=summon